Transferrin saturation versus reticulocyte hemoglobin content for iron deficiency in Japanese hemodialysis patients
- 1 March 2003
- journal article
- clinical trial
- Published by Elsevier in Kidney International
- Vol. 63 (3) , 1086-1093
- https://doi.org/10.1046/j.1523-1755.2003.00826.x
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- A randomized trial of iron deficiency testing strategies in hemodialysis patients11See Editorial by Besarab, p. 2412.Kidney International, 2001
- Factors determining the percentage of hypochromic red blood cells in hemodialysis patientsKidney International, 1999
- A study of parenteral iron regimens in hemodialysis patientsAmerican Journal of Kidney Diseases, 1999
- Hypochromic red cells and reticulocyte haemoglobin content as markers of iron-deficient erythropoiesis in patients undergoing chronic haemodialysisNephrology Dialysis Transplantation, 1999
- A randomized trial of three iron dextran infusion methods for anemia in EPO-treated dialysis patientsAmerican Journal of Kidney Diseases, 1998
- Optimal Iron Management in Patients Receiving Erythropoietin TherapySeminars in Dialysis, 1998
- Economic appraisal of maintenance parenteral iron administration in treatment of anaemia in chronic haemodialysis patientsNephrology Dialysis Transplantation, 1996
- The utility of zinc protoporphyrin for predicting the need for intravenous iron therapy in hemodialysis patientsAmerican Journal of Kidney Diseases, 1995
- Treatment of the Anemia of Progressive Renal Failure with Recombinant Human ErythropoietinNew England Journal of Medicine, 1989
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987